Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenecteplase in Acute Posterior Circulation Ischemic Stroke (4.5-24 Hours)
NCT07094763Recruiting
- Sponsor
- The First Affiliated Hospital of University of Science and Technology of China
- Start
- Nov 2025
- Primary completion
- Oct 2027
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Randomised, open-label trial of tenecteplase in ischemic stroke (2 arms), sponsored by The First Affiliated Hospital of University of Science and Technology of China. Primary endpoint: Proportion of patients with modified Rankin Scale score 0-1 at 90 days. Started Nov 2025; status: recruiting.
02
Drugs
tenecteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07094763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07094763.